NO852677L - Fremgangsmaate for fremstilling av 1,6-naftyridin-2(ih)-oner for bruk som kardiotoniske midler. - Google Patents
Fremgangsmaate for fremstilling av 1,6-naftyridin-2(ih)-oner for bruk som kardiotoniske midler.Info
- Publication number
- NO852677L NO852677L NO852677A NO852677A NO852677L NO 852677 L NO852677 L NO 852677L NO 852677 A NO852677 A NO 852677A NO 852677 A NO852677 A NO 852677A NO 852677 L NO852677 L NO 852677L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- methyl
- formula
- phenyl
- prepared
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/630,810 US4560691A (en) | 1984-07-13 | 1984-07-13 | 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO852677L true NO852677L (no) | 1986-01-14 |
Family
ID=24528649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO852677A NO852677L (no) | 1984-07-13 | 1985-07-03 | Fremgangsmaate for fremstilling av 1,6-naftyridin-2(ih)-oner for bruk som kardiotoniske midler. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4560691A (en]) |
| EP (1) | EP0168037B1 (en]) |
| JP (1) | JPS6140286A (en]) |
| KR (1) | KR870001089B1 (en]) |
| AR (1) | AR242388A1 (en]) |
| AT (1) | ATE50259T1 (en]) |
| AU (1) | AU584103B2 (en]) |
| DE (1) | DE3575926D1 (en]) |
| DK (1) | DK318985A (en]) |
| ES (1) | ES8706151A1 (en]) |
| FI (1) | FI852765L (en]) |
| GR (1) | GR851677B (en]) |
| IL (1) | IL75733A (en]) |
| MX (1) | MX161361A (en]) |
| NO (1) | NO852677L (en]) |
| NZ (1) | NZ212647A (en]) |
| PH (1) | PH21844A (en]) |
| PT (1) | PT80809B (en]) |
| ZA (1) | ZA855280B (en]) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4532247A (en) * | 1983-08-08 | 1985-07-30 | Sterling Drug Inc. | 5-(Hydroxyalkyl or alkanoyloxymethyl)-1,6-naphthyridin-2(1H)-one and cardiotonic use thereof |
| US4567186A (en) * | 1985-01-14 | 1986-01-28 | Sterling Drug Inc. | 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor |
| NZ214837A (en) * | 1985-01-28 | 1988-10-28 | Sterling Drug Inc | 5-substituted 1,6 naphthyridin-2(1h)-ones |
| DE3840341A1 (de) * | 1988-11-30 | 1990-06-07 | Basf Ag | Verfahren zur herstellung von 1-nitroanthrachinon-2-carbonsaeure |
| US7235551B2 (en) * | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| NZ524806A (en) | 2000-10-23 | 2006-03-31 | Smithkline Beecham Corp | Tri-substituted 8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| ES2291630T3 (es) * | 2002-04-19 | 2008-03-01 | Smithkline Beecham Corporation | Nuevos compuestos. |
| US7550480B2 (en) * | 2003-02-14 | 2009-06-23 | Smithkline Beecham Corporation | Compounds |
| UY29439A1 (es) * | 2005-03-25 | 2006-10-02 | Glaxo Group Ltd | Nuevos compuestos |
| MY145343A (en) | 2005-03-25 | 2012-01-31 | Glaxo Group Ltd | Novel compounds |
| JP2008537937A (ja) * | 2005-03-25 | 2008-10-02 | グラクソ グループ リミテッド | ピリド［２，３−ｄ］ピリミジン−７−オンおよび３，４−ジヒドロピリミド［４，５−ｄ］ピリミジン−２（１Ｈ）−オン誘導体の製造方法 |
| US20090137550A1 (en) * | 2005-03-25 | 2009-05-28 | Glaxo Group Limited | Novel Compounds |
| CN105218388B (zh) * | 2015-10-26 | 2017-07-11 | 西北农林科技大学 | β‑羰基烯胺类化合物及作为制备植物病原菌抗菌剂的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4412077A (en) * | 1982-03-15 | 1983-10-25 | Sterling Drug Inc. | Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone |
| US4415580A (en) * | 1982-08-02 | 1983-11-15 | Sterling Drug Inc. | Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same |
-
1984
- 1984-07-13 US US06/630,810 patent/US4560691A/en not_active Expired - Fee Related
-
1985
- 1985-07-03 NO NO852677A patent/NO852677L/no unknown
- 1985-07-04 NZ NZ212647A patent/NZ212647A/xx unknown
- 1985-07-05 IL IL75733A patent/IL75733A/xx unknown
- 1985-07-05 GR GR851677A patent/GR851677B/el unknown
- 1985-07-09 EP EP85108538A patent/EP0168037B1/en not_active Expired - Lifetime
- 1985-07-09 MX MX8266A patent/MX161361A/es unknown
- 1985-07-09 DE DE8585108538T patent/DE3575926D1/de not_active Expired - Fee Related
- 1985-07-09 AT AT85108538T patent/ATE50259T1/de not_active IP Right Cessation
- 1985-07-10 JP JP15215885A patent/JPS6140286A/ja active Pending
- 1985-07-10 AU AU44747/85A patent/AU584103B2/en not_active Ceased
- 1985-07-11 AR AR85300954A patent/AR242388A1/es active
- 1985-07-11 PH PH32510A patent/PH21844A/en unknown
- 1985-07-12 PT PT80809A patent/PT80809B/pt unknown
- 1985-07-12 KR KR1019850004976A patent/KR870001089B1/ko not_active Expired
- 1985-07-12 FI FI852765A patent/FI852765L/fi not_active Application Discontinuation
- 1985-07-12 ZA ZA855280A patent/ZA855280B/xx unknown
- 1985-07-12 DK DK318985A patent/DK318985A/da unknown
- 1985-07-12 ES ES545139A patent/ES8706151A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK318985A (da) | 1986-01-14 |
| EP0168037A3 (en) | 1986-03-26 |
| MX161361A (es) | 1990-09-18 |
| ATE50259T1 (de) | 1990-02-15 |
| ZA855280B (en) | 1986-02-26 |
| AU4474785A (en) | 1986-01-16 |
| KR870001089B1 (ko) | 1987-06-04 |
| IL75733A (en) | 1988-07-31 |
| FI852765A7 (fi) | 1986-01-14 |
| PT80809A (en) | 1985-08-01 |
| EP0168037B1 (en) | 1990-02-07 |
| AU584103B2 (en) | 1989-05-18 |
| PH21844A (en) | 1988-03-17 |
| KR860001109A (ko) | 1986-02-22 |
| JPS6140286A (ja) | 1986-02-26 |
| US4560691A (en) | 1985-12-24 |
| FI852765A0 (fi) | 1985-07-12 |
| FI852765L (fi) | 1986-01-14 |
| ES545139A0 (es) | 1987-06-01 |
| DE3575926D1 (de) | 1990-03-15 |
| NZ212647A (en) | 1988-07-28 |
| EP0168037A2 (en) | 1986-01-15 |
| PT80809B (en) | 1987-01-12 |
| AR242388A1 (es) | 1993-03-31 |
| ES8706151A1 (es) | 1987-06-01 |
| GR851677B (en]) | 1985-11-26 |
| IL75733A0 (en) | 1985-11-29 |
| DK318985D0 (da) | 1985-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH675722A5 (en]) | ||
| NO315855B1 (no) | Kondenserte 1,2,4-tiadiazinderivater, fremgangsmåte for deres fremstilling,anvendelse derav til fremstilling av medikamenter, samtfarmasöytiske preparater som omfatter derivatene, og fremgangsmåte for fremstilling avpreparatene | |
| NO852677L (no) | Fremgangsmaate for fremstilling av 1,6-naftyridin-2(ih)-oner for bruk som kardiotoniske midler. | |
| JPS62185073A (ja) | 抗不整脈剤 | |
| PT93823B (pt) | Processo para a preparacao de derivados de pirimidina e de composicoes farmaceuticas que os contem | |
| JPS62255480A (ja) | フエニルピペラジン抗不整脈剤 | |
| NO811040L (no) | Diaminopyridiner og fremgangsmaate til deres fremstilling | |
| US4465686A (en) | 5-(Hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones, their cardiotonic use and preparation | |
| US4415580A (en) | Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same | |
| US4524149A (en) | 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use | |
| US4412077A (en) | Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone | |
| US4599423A (en) | Preparation of 5-(hydroxy- and/or aminophenyl-6-lower-alkyl)-2(1H)-pyridinones | |
| EP0108380A2 (en) | Pyrido 2,3-d pyridimin-5-ones | |
| NO851066L (no) | Pyridinyl-2-pyrimidinaminer egnet som kardiotoniske midler samt fremstilling derav | |
| NO821046L (no) | 3-amino-5-(substituert)-2-(1h)-pyridinoner og fremgangsmaate for deres fremstilling | |
| NO803911L (no) | 3-acylamino-5-(pyridinyl)-2(1h)-pyridinoner og fremgangsmaate til fremstilling derav | |
| US4473571A (en) | 8-Substituted-2-(4-pyridinyl)-9H-purin-6-amines and their cardiotonic use | |
| US4532247A (en) | 5-(Hydroxyalkyl or alkanoyloxymethyl)-1,6-naphthyridin-2(1H)-one and cardiotonic use thereof | |
| US4559352A (en) | 1,2-Dihydro-2-oxo-5-(hydroxy-and/or amino-phenyl)-nicotinonitriles and cardiotonic use thereof | |
| US4515797A (en) | 3-Amino-5-(hydroxy- and/or aminophenyl)-6-(lower-alkyl)-2(1H)-pyridinones and cardiotonic use thereof | |
| US4559347A (en) | 3-Substituted-5-alkyl-1,6-naphthyridin-2(1H)-ones, cardiotonic use and preparation thereof | |
| US4517190A (en) | 5-Alkyl-1,6-naphthyridin-2(1H)-ones and cardiotonic use thereof | |
| NO821314L (no) | Pyrazolpyridinderivater og fremgangsmaate for deres fremstilling | |
| EP0017477A1 (en) | Spiro-quinolone hydantoins, pharmaceutical compositions containing them, and processes for their preparation | |
| US4604399A (en) | 5-methyl(or ethyl)-1,6-naphthyridin-2(1H)-one 6-oxides, their preparation and the cardiotonic use thereof |